Versant Ventures is a venture capital firm primarily focused on biotechnology and life sciences, with a strong emphasis on novel therapeutics addressing unmet medical needs. Their strategy involves both investing in external companies and actively building new biotech startups through their in-house "Discovery Engines" across North America and Europe.
Portfolio
1
Fund Size
$5.5B
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| Akero Therapeutics | Series B | $70M | Dec 2018 |
Top Co-Investors
Janus Henderson Investors1 shared
Redmile Group1 shared
Cormorant Asset Management1 shared
Rock Springs Capital1 shared
Apple Tree Partners1 shared
Atlas Venture1 shared
venBio1 shared
Last updated: 27 February 2026